The International Tennis Integrity Agency (ITIA) has confirmed that Luis Patiño, a 28-year-old Mexican tennis player, has been provisionally suspended under Article 7.12.1 of the 2022 Tennis Anti-Doping Programme (TADP). The ITIA sent the player a pre-charge notice of an Anti-Doping Rule Violation on 15 July under Article 7.12.2.2 of the TADP, confirming that the player is suspended from that date.

Patiño, who had a highest ATP Doubles ranking of 239, is being charged with Anti-Doping Rule Violations involving two S1 Anabolic Agents listed in the World Anti-Doping Agency (WADA) Prohibited List. While provisionally suspended, the player is ineligible to compete in or attend any tennis events authorised, organised or sanctioned by the governing bodies of the sport.

The ITIA is the delegated third party, under the World Anti-Doping Code of the International Tennis Federation, the international governing body for the sport of tennis and signatory of the Code. The ITIA is responsible for the management and administration of anti-doping across professional tennis in accordance with the 2022 TADP.

End

Notes to editors:

The player is being charged with breaches of:

TADP Article 2.2 which states that it is an Anti-Doping Rule Violation to Use or Attempt to Use a Prohibited Substance or a Prohibited Method, unless the Player establishes that such Use or Attempted Use is consistent with a TUE granted in accordance with Article 4.4.

And TADP Article 2.6, which states that it is an Anti-Doping Rule Violation for a Player to Possess In-Competition any Prohibited Substance or Prohibited Method, or Possess Out-of-Competition any Prohibited Substance or any Prohibited Method that is prohibited Out-of-Competition, unless the Player establishes that such Possession is consistent with a TUE granted in accordance with Article 4.4 or other acceptable justification.

Published 29 July 2022 11:30

Tennis you can trust

Protect the sport

Make the right call - if you are worried that corruption or doping may be taking place, share your concerns with us.